AILERON THERAPEUTICS INC's ticker is ALRN and the CUSIP is 00887A105. A total of 48 filers reported holding AILERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $39,000 | +30.0% | 190,691 | +65.5% | 0.00% | – |
Q2 2022 | $30,000 | 0.0% | 115,191 | +96.9% | 0.00% | – |
Q1 2022 | $30,000 | -88.7% | 58,500 | -87.6% | 0.00% | – |
Q4 2021 | $265,000 | -64.6% | 470,440 | -36.0% | 0.00% | -100.0% |
Q3 2021 | $749,000 | -41.9% | 734,721 | -28.7% | 0.00% | -50.0% |
Q2 2021 | $1,289,000 | -27.9% | 1,031,128 | -17.5% | 0.00% | 0.0% |
Q1 2021 | $1,788,000 | +170.9% | 1,250,500 | +97.1% | 0.00% | +100.0% |
Q4 2020 | $660,000 | -57.5% | 634,381 | -47.3% | 0.00% | -50.0% |
Q3 2020 | $1,554,000 | -4.8% | 1,204,411 | -13.0% | 0.00% | +100.0% |
Q2 2020 | $1,633,000 | +933.5% | 1,383,881 | +190.0% | 0.00% | – |
Q1 2020 | $158,000 | -43.8% | 477,181 | -2.8% | 0.00% | – |
Q4 2019 | $281,000 | +23.2% | 491,081 | +44.3% | 0.00% | – |
Q3 2019 | $228,000 | +60.6% | 340,248 | +73.1% | 0.00% | – |
Q2 2019 | $142,000 | -49.1% | 196,548 | +37.1% | 0.00% | – |
Q1 2019 | $279,000 | +65.1% | 143,310 | -28.7% | 0.00% | – |
Q4 2018 | $169,000 | +23.4% | 200,980 | +304.1% | 0.00% | – |
Q3 2018 | $137,000 | – | 49,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 69,350 | $928,000 | 0.28% |
SPHERA FUNDS MANAGEMENT LTD. | 125,000 | $1,673,000 | 0.24% |
Candriam S.C.A. | 150,000 | $2,007,000 | 0.04% |
MASTERS CAPITAL MANAGEMENT LLC | 30,000 | $401,000 | 0.01% |
JENNISON ASSOCIATES LLC | 249,344 | $3,336,000 | 0.00% |
Laurion Capital Management LP | 30,000 | $401,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 36,931 | $494,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 314 | $4,000 | 0.00% |
NORTHERN TRUST CORP | 19,011 | $254,000 | 0.00% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 607 | $8,000 | 0.00% |